Search

Author/Creator Lucas, Prisca

1. Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials. Issue 1 (December 2016)

Authors:
Vandenberghe, Rik; Rinne, Juha; Boada, Mercè; Katayama, Sadao; Scheltens, Philip; Vellas, Bruno; Tuchman, Michael; Gass, Achim; Fiebach, Jochen; Hill, Derek; Lobello, Kasia; Li, David; McRae, Tom; Lucas, Prisca; Evans, Iona; Booth, Kevin; Luscan, Gerald; Wyman, Bradley; Hua, Lisa; Yang, Lingfeng
Journal:
Alzheimer's research & therapy
Issue:
Volume 8:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies. Issue 1 (December 2016)

Authors:
Ivanoiu, Adrian; Pariente, Jérémie; Booth, Kevin; Lobello, Kasia; Luscan, Gerald; Hua, Lisa; Lucas, Prisca; Styren, Scot; Yang, Lingfeng; Li, David; Black, Ronald; Brashear, H.; McRae, Thomas
Journal:
Alzheimer's research & therapy
Issue:
Volume 8:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P2‐015: Pooled Amyloid Pet Baseline Data from The Bapineuzumab IV Phase III Trials. (1st July 2016)

Authors:
Hill, Derek L.; Novak, Gerald P.; Wolz, Robin; Liu, Enchi; Lucas, Prisca; Fox, Nick C.; Scheltens, Philip; Gray, Katherine R.; Booth, Kevin; Einstein, Steven G.; Schmidt, Mark E.; Li, David Jianjun; Styren, Scot D.; Margolin, Richard A.; McCarthy, Timothy J.; Brashear, Robert Robert
Journal:
Alzheimer's & dementia
Issue:
Volume 12:Supplement 7S(2016)Part 12
Page Start:
P614
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗